Search results
Positron Emission Tomography is an invaluable and perhaps most important tool for assessing cancer in vivo. Dr. Burrell provides a quick overview of the types of imaging used in oncology,…
Taking novel imaging probes from discovery in a lab setting, through full development and on to manufacturing and clinical trials is one of the goals of the MITNEC program and…
The ability to calculate tissue perfusion accurately is clinically important challenge. Using magnetic resonance imaging, Dr. Frayne discusses two approaches to perfusion calculations; time-tested exogenous methods using tracer kinetic models…
The ability to determine the functional significance of coronary stenosis and myocardium at risk in the clinical emergency setting is an important goal of myocardial perfusion studies. Here, Dr. Lee…
Responding to the impending shut down of reactor facilities and a call for further research, deKemp et al. are exploring alternative agents for PET imaging of the heart that do…
Using imaging to help unravel the complex relationships between vascular disease and cognitive impairment is the outline for this presentation. Imaging metrics can be quantified and used to identify disease…
The Ottawa Heart Institute is active in the development of novel radiopharmaceutical agents for PET imaging of cardiac diseases. Dr. DaSilva describes several tracer development programs at the OHI, together…
As the Director of the Evaluation of Radiopharmaceuticals and Biotherapeutic Products at Health Canada, Dr. Klein gives a brief background on the introduction of the Food and Drug Act in…